Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/1748
Title: Exploring the impact of providing men with information about potential prostate cancer treatment options prior to receiving biopsy results
Authors: Moon, Daniel
Pillay, Brindha
Crowe, Helen
Wotten, Addie
Frydenberg, Mark
Howard, Nocholas
Other Authors: Meyer, Denny
Mann, Sarah
Keywords: Prostate Cancer
PCa
Prostatic Neoplasms
Prostate
Men
Health information
Treatment Decision Aid
Treatment Options
Treatment Decisional Conflict
Depression
Anxiety
Distress
Distress Thermometer
Generalised Anxiety Disorder-7
Patient Health Questionnaire-9
Decisional Conflict Scale
Australian Urology Practice
Prostate Biopsy
Pre-Biopsy
Post-Biopsy
Elevated PSA test
Suspicious Digital Rectal Exam
Epworth Prostate Centre, Epworth Healthcare
Epworth Centre for Robotic Surgery, Epsworth Healthcare
Clinical Institute of Specialty Surgery, Epworth Healthcare
Epworth Healthcare
Issue Date: May-2019
Publisher: Springer
Citation: (2019). Exploring the impact of providing men with information about potential prostate cancer treatment options prior to receiving biopsy results. Supportive Care in Cancer, 1-8.
Abstract: There is little research assessing the impact of providing men with information about prostate cancer (PCa) treatment options at the time of referral for a prostate biopsy. Study objectives were to determine whether receiving an information booklet about PCa treatment options prior to receiving biopsy results was acceptable to patients, and if receiving this information influenced levels of anxiety, depression, distress, and treatment decisional conflict. Between June 2016 and September 2017, a randomised block design was used to allocate patients from an Australian urology practice into the intervention or control group. Patients in the intervention group were provided with written information about treatment options for localised PCa prior to their biopsy. Outcome measures including the Distress Thermometer, Generalised Anxiety Disorder-7, Patient Health Questionnaire-9, and Decisional Conflict Scale were completed pre-biopsy and 2-3 weeks post-biopsy. Ninety-eight patients referred for an initial prostate biopsy for an elevated PSA test or suspicious digital rectal exam participated in the study (response rate = 78%). Multimodal repeated-measures analyses showed no significant differences between control and intervention groups in changes in distress, anxiety, or depression from pre- to post-biopsy, and in decisional conflict post-diagnosis (all p > .05). Thirty-five (87%) patients believed that the resource made it easier to understand subsequent explanation of treatment options, and 51 patients (98%) who received the intervention preferred to be given information at that time.
URI: http://hdl.handle.net/11434/1748
DOI: 10.1007/s00520-019-04847-5
PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/31065839/
ISSN: 0941-4355
Journal Title: Supportive care in cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Type: Journal Article
Affiliated Organisations: Urology, Royal Melbourne Hospital, Melbourne, Australia.
Psychosocial Oncology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.
Australian Urology Associates, Melbourne, Australia.
University of Melbourne, Melbourne, Australia.
School of Health Sciences, Swinburne University of Technology, Melbourne, Australia.
Australian Prostate Centre, North Melbourne, Australia.
Urology, Monash Health, Melbourne, Australia.
Department of Surgery, Monash University, Melbourne, Australia.
Type of Clinical Study or Trial: Randomised Block Design
Multimodal Repeated-Measures Analysis
Appears in Collections:Cancer Services
Epworth Prostate Centre
UroRenal, Vascular

Files in This Item:
There are no files associated with this item.


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.